Antidiabetic activity of aqueous bark extract of Cassia glauca in streptozotocin-induced diabetic rats

Canadian Journal of Physiology and Pharmacology

Volumn 88, Issue 2, 2010, Pages 153-160

  Salahuddin, Md ^a   Jalalpure, Sunil S ^a   Gadge, Navneet B ^a  

^a K L E S S COLLEGE OF PHARMACY   (India)

Author keywords

Antidiabetic; Cassia glauca; Glibenclamide; Lipid profile; OGTT

Indexed keywords

CASSIA EXTRACT; CHOLESTEROL; CREATININE; GLIBENCLAMIDE; GLUCOSE; GLYCOGEN; GLYCOSYLATED HEMOGLOBIN; INSULIN; TRIACYLGLYCEROL; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BARK; BODY WEIGHT; CASSIA GLAUCA; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; HISTOPATHOLOGY; INSULIN BLOOD LEVEL; MEDICINAL PLANT; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL;

ANIMALS; BLOOD GLUCOSE; CASSIA; DIABETES MELLITUS, EXPERIMENTAL; HYPOGLYCEMIC AGENTS; PHYTOTHERAPY; PLANT BARK; PLANT EXTRACTS; RATS; RATS, WISTAR; WATER;

EID: 77649090567     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y09-121     Document Type: Conference Paper

References (41)

1. Abou El-Soud, N.H., Khalil, M.Y., Hussein, J.S., Oraby, F.S.H., and Hussein Farrag, A.R. 2007. Antidiabetic effects of fenugreek alkaloid extract in streptozotocin induced hyperglycemic rats. J. Appl. Sci. Res. 3(10): 1073-1083.
2. Amos, A.F., McCarty, D.J., and Zimmet, P. 1997. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Dia Med. 14: 1-85.
3. Aslan, M., Deliorman Orhan, D., Orhan, N., Sezik, E., and Yesilada, Yesilada, E. 2007. In vivo antidiabetic and antioxidant potential of Helichrysum plicatum ssp. plicatum capitulums in streptozotocin-induced-diabetic rats. J. Ethnopharmacol. 109(1): 54-59. doi:10.1016/j.jep.2006.07.001. PMID:16949229.
4. Babu, V., Gangadevi, T., and Subramoniam, A. 2003. Antidiabetic activity of ethanol extract of Cassia kleinii leaf in streptozotocin-induced diabetic rats and isolation of an active fraction and toxicity evaluation of the extract. Indian J. Pharmacol. 35: 290-296.
5. Bailey, C.J., and Day, C. 1989. Traditional plant medicines as treatments for diabetes. Diabetes Care, 12(8): 553-564. doi:10.2337/diacare.12.8. 553. PMID:2673695.
6. Bairy, K.L., Sharma, A., and Shalini, A. 2005. Evaluation of the hypoglycemic, hypolipidemic and hepatic glycogen raising effects of Syzygium malaccense upon streptozotocin induced diabetic rats. J. Nat. Rem. 5(1): 46-51.
7. Bhattaram, V.A., Ceraefe, M., Kohlest, C., Vest, M., and Deundort, H. 2002. Pharmacokinetics and bioavailability of herbal medicine products. Phytomed. 9: 1-33. doi:10.1078/1433-187X-00210.
8. Brain, R., Margaret, C.C., Jian, K., Ramesh, K.G., and John, H.M. 1997. Strain differences in susceptibility to streptozotocin-induced diabetes: effects on hypertriglyceridemia and cardiomyopathy. Card. Res. 34(1): 199-205. doi:10.1016/S0008-6363(97)00045-X.
9. Carney, J.R., Krenisky, J.M., Williamson, R.T., Luo, J., Carlson, T.J., Hsu, V.L., and Moswa, J.L. 1999. Maprouneacin, a new daphnane diterpenoid with potent antihyperglycemic activity from Maprounea africana. J. Nat. Prod. 62(2): 345-347. doi:10.1021/np980356c. PMID:10075783.
10. Carroll, N.V., Longley, R.W., and Roe, J.H. 1956. The determination of glycogen in liver and muscle by use of anthrone reagent. J. Biol. Chem. 220: 583-593.
11. Chakrabarti, S., Biswas, T.K., Seal, T., Rokeya, B., Ali, L., Azad Khan, A.K., et al. 2005. Antidiabetic activity of Caesalpinia bonducella F. in chronic type 2 diabetic model in Long-Evans rats and evaluation of insulin secretagogue property of its fractions on isolated islets. J. Ethnopharmacol. 97(1): 117-122. doi:10.1016/j.jep.2004.10.025. PMID:15652285.
12. De Tommasi, N., De Simone, F., Cirino, G., Cicala, C., and Pizza, C. 1991. Hypoglycemic effects of sesquiterpene glycosides and polyhydroxylated triterpenoids of Eriobotrya japonica. Planta Med. 57(5): 414-416. doi:10.1055/s-2006-960137. PMID:1798792.
13. Drabkin, D.L., and Austin, J.M. 1932. Spectrophotometric constants for common haemoglobin derivatives in human dog and rabbit blood. J. Biol. Chem. 98: 719-733.
14. Eisenbarth, G.S., Ziegler, A.G., and Colman, P.A. 1994. Pathogenesis of insulin dependent (type 1) diabetes mellitus. In Joslin's diabetes mellitus. Edited by C.R. Kahn and G.C. Weir. 13th ed. Lea & Febiger, Philadelphia. pp. 216-239.
15. Elder, C. 2004. Ayurveda for diabetes mellitus: a review of the biomedical literature. Altern. Ther. Health Med. 10(1): 44-50. PMID:14727499.
16. Eshrat, H.M. 2003. Effect of Coccinia indica (L.) and Abroma augusta (L.) on glycemia, lipid profile and on indicators of end-organ damage in streptozotocin induced diabetic rats. Indian J. Clin. Biochem. 18(2): 54-63. doi:10.1007/BF02867368.
17. Grover, J.K., Yadav, S., and Vats, V. 2002. Medicinal plants of India with anti-diabetic potential. J. Ethnopharmacol. 81(1): 81-100. doi:10.1016/S0378-8741(02)00059-4. PMID:12020931.
18. Harborne, J.B. 1998. Phytochemical methods: a guide to modern techniques of plant analysis. Chapman and Hall, London. p. 60.
19. Harold, V. 1976. Estimation of total serum cholesterol. In Practical clinical biochemistry. 4th ed. Arnold Heinemann, India. p. 313.
20. Hemlata, and Kalidhar, S.B. 1994. Chemical components of Cassia glauca Lam. Indian J. Pharmaceut. Sci. 56(1): 33-34.
21. Jain, S.R. 1968. Hypoglycemic principle in the Musa sapeintum and its isolation. Planta Med. 16: 43-47. doi:10.1055/s-0028-1099878.
22. Jalalpure, S.S., Patil, M.B., Pai, A., Shah, B.N., and Salahuddin, M.D. 2004. Antidiabetic activity of Cassia auriculata seeds in alloxan induced diabetic rats. Niger. J. Nat. Prod. Med. 8: 37-38.
23. Kadnur, S.V., and Goyal, R.K. 2005. Comparative antidiabetic activity of methanolic extract and ethyl acetate extract of Zingiber officinale Roscoe. Indian J. Pharm. Sci. 67: 453-457.
24. King, H., Aubert, R.E., and Herman, W.H. 1998. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care, 21(9): 1414-1431. doi:10.2337/diacare.21.9.1414. PMID:9727886.
25. Kirtikar, K.R., and Basu, B.D. 1935. In Indian medicinal plants. Lalit Mohan Basu Publications, Allahabad, India. pp. 1139-1141.
26. Kokate, C.K. 1994. In Practical pharmacognosy. Vallabh Prakashan, New Delhi, India. pp. 105-107.
27. Kratzsch, J., Ackermann, W., Keilacker, H., Besch, W., and Keller, E. 1990. A sensitive sandwich enzyme immunoassay for measurement of insulin on microtiter plates. Exp. Clin. Endocrinol. 95(2): 229-236. doi:10.1055/s-0029-1210957. PMID:2194826.
28. Latha, M., and Pari, L. 2003. Preventive effects of Cassia auriculata L. flowers on brain lipid peroxidation in rats treated with streptozotocin. Mol. Cell. Biochem. 243(1-2): 23-28. doi:10.1023/A: 1021697311150. PMID:12619885.
29. Latha, M., and Pari, L. 2004. Effect of an aqueous extract of Scoparia dulcis on blood glucose, plasma insulin and some polyol pathway enzymes in experimental rat diabetes. Braz. J. Med. Biol. Res. 37(4): 577-586. doi:10.1590/S0100-879X2004000400015. PMID:15064821.
30. Marx, J. 2002. Unraveling the causes of diabetes. Science, 296(5568): 686-689. doi:10.1126/science.296.5568.686. PMID:11976439.
31. Mitra, S.K., Gopumadhavan, S., Muralidhar, T.S., Anturlikar, S.D., and Sujatha, M.B. 1996a. Effect of a herbomineral preparation D-400 in streptozotocin-induced diabetic rats. J. Ethnopharmacol. 54(1): 41-46. doi:10.1016/0378-8741(96)01439-0. PMID:8941867.
32. Mitra, S.K., Gopumadhavan, S., and Nuralidhar, T.S. 1996b. Effect of D-400, an Ayurvedic herbal formulation on experimentallyinduced diabetes mellitus. Phyto Res. 10(5): 433-435. doi:10.1002/(SICI)1099-1573(199608) 10:5 <433::AID-PTR864> 3.0.CO;2-D.
33. Morel, D.W., and Chisolm, G.M. 1989. Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. J. Lipid Res. 30(12): 1827-1834. PMID:2621411.
34. Pari, L., and Latha, M. 2002. Antidiabetic activity of Cassia auriculata flowers: Effect on lipid per oxidation in streptozotocin diabetes rats. Pharm. Biol. 40(7): 512-517. doi:10.1076/phbi.40.7.512.14683.
35. Seifter, S., and England, S. 1982. In The liver: biology and pathology. Raven Press, New York. pp. 219-249.
36. Sharma, S.R., Dwivedi, S.K., and Swarup, D. 1997. Hypoglycaemic, antihyperglycaemic and hypolipidemic activities of Caesalpinia bonducella seeds in rats. J. Ethnopharmacol. 58(1): 39-44. doi:10.1016/S0378- 8741(97)00079-2. PMID:9324003.
37. Shirwaikar, A., and Rajendran, K. 2006. Effect of aqueous bark extract of Garuga pinnata Roxb. in streptozotocin-nicotinamide induced type-II diabetes mellitus. J. Ethnopharmacol. 112: 1-6.
38. Shirwaikar, A., Rajendran, K., and Kumar, C. 2004. Oral antidiabetic activity of Annona squamosa leaf alcohol extract in NIDDM rats. Pharmaceut. Biol. 42(1): 30-35. doi:10.1080/13880200490505438.
39. Swanston-Flatt, S.K., Day, C., Bailey, C.J., and Flatt, P.R. 1990. Traditional plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetologia, 33(8): 462-464. doi:10.1007/BF00405106. PMID:2210118.
40. Tiwari, A.K., and Madhusudana, R.J. 2002. Diabetes mellitus and multiple therapeutic approaches of phytochemicals: present status and future prospects. Curr. Sci. 83: 30-38.
41. Toro, G., and Ackermann, P.G. 1975. In Practical clinical chemistry. Little Brown and Co., Boston, Mass. p. 154.